Iran J Pharm Res

Image Credit:Iran J Pharm Res

Erratum: Secondary Autoimmune Dermatological Disorders Induced by Multiple Sclerosis Biological Immunotherapy Agents: A Systematic Review of Case Reports [IJ Pharm Res. 2025; 24 (1): e166426]

Author(s):
Mohammad Ali SahraianMohammad Ali Sahraian1, Shahaboddin EmamiShahaboddin Emami2, 3, Sara AtaeiSara Ataei4, Fahime Nasr EsfahaniFahime Nasr Esfahani5, Nasibeh GhalandariNasibeh GhalandariNasibeh Ghalandari ORCID2,*
1Department of Neurology, Multiple Sclerosis Research Center, Neuroscience Institute, Sina Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
2Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
3Medicinal Plants and Natural Products Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran
4Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
5Tehran University of Medical Sciences, Tehran, Iran

IJ Pharmaceutical Research:Vol. 24, issue 1; e169319
Published online:Dec 28, 2025
Article type:Correction
Received:Dec 23, 2025
Accepted:Dec 24, 2025
How to Cite:Sahraian MA, Emami S, Ataei S, Nasr Esfahani F, Ghalandari N. Erratum: Secondary Autoimmune Dermatological Disorders Induced by Multiple Sclerosis Biological Immunotherapy Agents: A Systematic Review of Case Reports [IJ Pharm Res. 2025; 24 (1): e166426]. Iran J Pharm Res. 2025;24(1):e169319. doi: https://doi.org/10.5812/ijpr-169319

Dear Readers,
Following the publication of a recently published article, an error was identified in the authorship information (1).
The name of the second author was published incorrectly. The correct name is Shahaboddin Emami.
In addition, the second author has two affiliations. The second affiliation is as follows:
Medicinal Plants and Natural Products Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran
These corrections do not affect the scientific content of the article. The authors apologize for this error and any inconvenience it may have caused to the readers.
Sincerely Yours
Nasibeh Ghalandari
Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
The Corresponding Author

References

  • 1.
    Sahraian MA, Emami S, Ataei S, Nasr Esfahani F, Ghalandari N. Secondary Autoimmune Dermatological Disorders Induced by Multiple Sclerosis Biological Immunotherapy Agents: A Systematic Review of Case Reports. IJ Pharm Res. 2025;24(1). e166426. https://doi.org/10.5812/ijpr-166426.

Similar Articles

17
Nov
2024

Erratum for Are There any Possible Side Effects of Neurofeedback? A Systematic Literature Review and Meta-analysis [Iran J Psychiatry Behav Sci. 2023;17(3):e138064]

Editor-in-Chief IJPBS

IJPBS E. Erratum for Are There any Possible Side Effects of Neurofeedback? A Systematic Literature Review and Meta-analysis [Iran J Psychiatry Behav Sci. 2023;17(3):e138064]. Iran J Psychiatry Behav Sci. 2024;18(4):e158140. doi: https://doi.org/10.5812/ijpbs-158140

17
Nov
2024

Erratum for Autism Spectrum Disorder is Related to Increasing Intestinal Prevotella That Can Be Regulated by Vitamin A [Iran J Psychiatry Behav Sci. 2023;17(2):e126508]

Editor-in-Chief IJPBS

IJPBS E. Erratum for Autism Spectrum Disorder is Related to Increasing Intestinal Prevotella That Can Be Regulated by Vitamin A [Iran J Psychiatry Behav Sci. 2023;17(2):e126508]. Iran J Psychiatry Behav Sci. 2024;18(4):e158137. doi: https://doi.org/10.5812/ijpbs-158137

27
Jan
2026
Jundishapur J Nat Pharm Prod

Erratum: Allicin Alleviates Aortic Dissection Progression via p38/MAPK/NF-κB Signaling Pathways [Jundishapur J Nat Pharm Prod. 2025; 20 (4): e165405]

Chang Ren,
Wuyi Ban,
Ru Chen,
Jun Gu,
Liying Qiu,
Lei Song

Ren C, Ban W, Chen R, Gu J, Qiu L, et al. Erratum: Allicin Alleviates Aortic Dissection Progression via p38/MAPK/NF-κB Signaling Pathways [Jundishapur J Nat Pharm Prod. 2025; 20 (4): e165405]. Jundishapur J Nat Pharm Prod. 2026;21(1):e168126. doi: https://doi.org/10.5812/jjnpp-168126

17
Jan
2015

Corrigendum to: Comparing the Effects of Morphine Sulfate and Diclofenac Suppositories on Postoperative Pain in Coronary Artery Bypass Graft Patients (published in a Oct 30, 2014; Anesthesiology and Pain Medicine. 4(4): e19423, DOI: 10.5812/aapm.19423

Valiollah Hassani

Hassani V. Corrigendum to: Comparing the Effects of Morphine Sulfate and Diclofenac Suppositories on Postoperative Pain in Coronary Artery Bypass Graft Patients (published in a Oct 30, 2014; Anesthesiology and Pain Medicine. 4(4): e19423, DOI: 10.5812/aapm.19423. Anesth Pain Med. 2015;5(1):e61533. doi: https://doi.org/10.5812/aapm.25875

27
Feb
2024
Iran J Pharm Res

Erratum: Review on Approved and Inprogress COVID-19 Vaccines

Editor-in-Chief IJPR

IJPR E. Erratum: Review on Approved and Inprogress COVID-19 Vaccines. Iran J Pharm Res. 2024;23(1):e146470. doi: https://doi.org/10.5812/ijpr-146470


Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles